Related Experiment Video
Updated: Aug 18, 2026

Acute Myocardial Infarction in Rats
Published on: February 17, 2011
Angiotensin-converting enzyme in acute myocardial infarction and angina pectoris
Insights
Serum angiotensin-converting enzyme activity showed no significant changes in most patients with myocardial infarction or angina. A notable decrease in two infarction patients was not clinically explained, suggesting this enzyme assay has limited diagnostic value for these cardiac conditions.
Area of Science:
- Cardiology
- Biochemistry
- Enzymology
Background:
- Acute myocardial infarction and angina pectoris are critical cardiovascular conditions.
- Angiotensin-converting enzyme (ACE) plays a role in cardiovascular regulation.
- Understanding biomarkers for cardiac events is crucial for patient management.
Purpose of the Study:
- To investigate the changes in serum angiotensin-converting enzyme (ACE) activity in patients with acute myocardial infarction (AMI) and angina pectoris.
- To determine the potential diagnostic or prognostic value of ACE activity in these cardiac conditions.
Main Methods:
- Serial analysis of serum ACE activity was performed.
- Measurements were taken over a 6-day observation period.
- Patient cohorts included 19 with AMI and 8 with angina pectoris.
Main Results:
- In most patients, serum ACE activity remained unchanged during the 6-day observation period.
- Two patients with myocardial infarction showed a significant decrease in ACE activity.
- This observed decrease in enzyme activity could not be correlated with any specific clinical events.
Conclusions:
- Serum ACE activity measurements do not appear to be a reliable indicator for the diagnosis or management of acute myocardial infarction.
- The clinical significance of observed fluctuations in ACE activity in cardiac patients requires further investigation.
- Current findings suggest limited utility of this specific enzyme assay in routine cardiac patient care.
Abstract:
Serum activity of angiotensin-converting enzyme was measured by serial analysis in 19 patients with acute myocardial infarction and in eight patients with angina pectoris. As a rule no changes in enzyme activity occurred during 6 days observations. However, two patients with infarction exhibited a pronounced fall of enzyme activity which could not be related to clinical events. The analysis seems to have no place in the diagnosis and management of patients with myocardial infarction.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Angina I: Introduction
Angina II: Classification

